(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 5.76% is forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 3.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.48%.
Cognex's revenue in 2025 is $929,555,000.On average, 3 Wall Street analysts forecast CGNX's revenue for 2025 to be $161,492,487,475, with the lowest CGNX revenue forecast at $160,147,112,708, and the highest CGNX revenue forecast at $163,315,367,027. On average, 3 Wall Street analysts forecast CGNX's revenue for 2026 to be $176,215,047,965, with the lowest CGNX revenue forecast at $172,264,384,260, and the highest CGNX revenue forecast at $182,220,795,553.
In 2027, CGNX is forecast to generate $184,353,112,980 in revenue, with the lowest revenue forecast at $184,353,112,980 and the highest revenue forecast at $184,353,112,980.